MALAT1 and breast carcinoma: Arun et al. also showed that using MALAT1-specific antisense oligonucleotides (ASO) to knock down the MALAT1 gene in a mouse breast cancer model resulted in slower primary tumor growth, increased differentiation, and reduced metastasis [47].